fda

As we wrote last week, the road to federal legalization may not be clear, but seems to be gaining momentum. Legalization would be a monumental win not only for cannabis culture, but also the future of medicinal alternatives. As long as pot is labeled a Schedule I drug, cannabis research is a...

The Food and Drug Administration (FDA) has a message for companies trying to hawk marijuana-based products as ones that can "prevent, diagnose, treat, or cure cancer" with zero evidence supporting that assertion: Knock it off, immediately. "Substances that contain components of marijuana will...

As part of the U.S. Food and Drug Administration's ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these...

This time next year, an investigational drug hailed as a breakthrough in the science of cannabidiol could be prescribed to children suffering from treatment-resistant epilepsy. The prospect of its success, however, has caused some unease in the American hemp industry. London-based GW...

A new store is open in Topeka and it's the first of it's kind in the capital city. The store is called CBD and they offer a variety of hemp products that contain CBD. The CEO and founder of CBD American Shaman said, "Hemp is a great source of CBD and guess what, it's legal." CBD oil is...

Speak to the average person about cannabis and they may feel inclined to lower their voice. Perhaps briefly recall memories of wild nights in their college dorm, or never partook, but had friends who did. Some may have particularly strong views on it, based on general beliefs or personal...

Pierre – A South Dakota panel on Wednesday approved a measure aimed at legalizing a medical marijuana extract used to treat severe seizure disorders. The House Health and Human Services Committee on a 7-3 vote approved Senate Bill 95, which would reschedule cannabidiol, a derivative of...

Amid the hailstorm of statistics loosed by recent 'current events,' one set showed that U.S. adults now approve of legalizing cannabis in landslide numbers. Nevertheless, the DEA again refused to endorse the drug earlier this year based on an array of research which, it turns out, indicates risk...

With a handful of states slated to vote on either medical or full marijuana legalization this November, the pressure is on for the federal government to perhaps reassess its dated policies on the drug. After all, there's no shortage of evidence the legal and cultural stigmas attached to the drug...

With a handful of states slated to vote on either medical or full marijuana legalization this November, the pressure is on for the federal government to perhaps reassess its dated policies on the drug. After all, there's no shortage of evidence the legal and cultural stigmas attached to the drug...

Remember how the Drug Enforcement Administration refused to change marijuana's legal status under federal law in August? Reform advocates protested that the decision proved that the government's current drug scheduling system was flawed - and the Food and Drug Administration apparently agrees...

British biotech company GW Pharmaceuticals announced positive results on its latest Phase 3 clinical trial for its drug Epidiolex. The drug is cannabidiol-based and is used to treat children with Lennox-Gastaut syndrome, a rare form of childhood epilepsy. The results from the test were very...

British biotech company GW Pharmaceuticals announced positive results on its latest Phase 3 clinical trial for its drug Epidiolex. The drug is cannabidiol-based and is used to treat children with Lennox-Gastaut syndrome, a rare form of childhood epilepsy. The results from the test were very...

Shares of INSYS Therapeutics Inc are trading 15 percent higher this morning, after the company announced that its cannabis-based medication has been approved by the United States Food and Drug Administration (FDA). The innovative drug, which is called Syndros, is an orally taken liquid form of a...

Shares of INSYS Therapeutics Inc are trading 15 percent higher this morning, after the company announced that its cannabis-based medication has been approved by the United States Food and Drug Administration (FDA). The innovative drug, which is called Syndros, is an orally taken liquid form of a...

The Food and Drug Administration has issued a warning that some cannabis oils and other products may not contain the ingredients found on the label, and may not help patients who use them to treat diseases. In February, the FDA sent warning letters to 18 firms that market cannabis products. The...

Hemp oil extracts containing CBDs (cannibidiols) are such a threat to the pharmaceutical industry that the FDA is now invoking totally insane justifications for outlawing them. CBDs are non-psychoactive compounds found naturally in hemp plants. They work so well as powerful natural medicine...

On February 9, the FDA sent out a number of warning letters to companies that make and sell products containing cannabidiol (CBD), a type of cannabinoid found in marijuana. Some of the products that the FDA tested contained no CBD in them at all. Even more troubling, many of the products...

Online peddlers of hemp-based cure-alls got another round of warning letters from the Food and Drug Administration earlier this month, the latest in federal efforts to push back on post-modern snake oil salesmen. In letters dated February 4, the FDA warned eight online hemp oil sellers – ABC...

The Register published an editorial Dec. 29 [Remove barriers to marijuana research] on rescheduling cannabis and the FDA's role. It seems everyone has an opinion on what should be done about cannabis as a treatment. But whose opinion matters most? The sick and dying – who most desperately need...